Skip to content
Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in

Psychedelics Company Profiles

Click on a company name below to view key financials, press releases and interviews.

Atai Life Sciences Logo White

ATAI Life Sciences

Beckley Psytech Company Profile

Beckley Psytech

Better Plant Sciences Company Profile

Better Plant Sciences (PLNT)

CaaMTech Company Profile

CaaMTech

Champignon Brands Company Profile

Champignon Brands Inc. (SHRM)

Compass Pathways Company Profile

COMPASS Pathways (CMPS)

Cybin Company Profile

Cybin Inc.

Eleusis Company Profile

Eleusis

Entheon Biomedical

Field Trip FTRP Company Profile

Field Trip (FTRP)

Havn Life Company Profile

Havn Life (HAVN)

Hollister Biosciences Company Profile

Hollister Biosciences (HOLL)

MagicMed Company Profile

MagicMed Industries

MindMed MMED Company Profile

MindMed (MMED)

Mydecine Innovations Company Profile

Mydecine Innovations Group (MYCO)

Numinus Company Profile

Numinus (NUMI)

Revive Therapeutics Company Profile

Revive Therapeutics Ltd. (RVV)

AI-powered Search

Your Pα+ account

Sign in

Quick Links

  • InsightsOpens in a new tab
  • JobsOpens in a new tab
  • DataOpens in a new tab
  • Subscribe to Pα+Opens in a new tab
  • ContactOpens in a new tab
  • The Psychedelic Practitioner - Issue 1 October 2025
    The Psychedelic Practitioner: Issue 1October 9, 2025
  • Q3 2025 Psychedelic Investor Survey Topline Header
    Psychedelic Investor Survey Q3 2025October 7, 2025
  • The Psychedelic News Feed: Sept 29 – Oct 5, 2025October 6, 2025
  • Pα+ Psychedelic Bulletin #210: Compass Exec Defends Minimal Support Model in Stockholm; IV Ketamine Outperforms Esketamine Nasal Spray in Retrospective Study; Reunion Advances RE104 in Adjustment Disorder; Mindstate Wraps Phase IOctober 3, 2025
  • The Psychedelic News Feed September 22-28, 2025
    The Psychedelic News Feed: September 22 – 28, 2025September 29, 2025

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More